Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

Autoimmunity to antigens of the central nervous system is usually considered detrimental. T cells specific to a central nervous system self antigen, such as myelin basic protein, can indeed induce experimental autoimmune encephalomyelitis, but such T cells may nevertheless appear in the blood of healthy individuals. We show here that autoimmune T cells specific to myelin basic protein can protect injured central nervous system neurons from secondary degeneration. After a partial crush injury of the optic nerve, rats injected with activated anti–myelin basic protein T cells retained approximately 300% more retinal ganglion cells with functionally intact axons than did rats injected with activated T cells specific for other antigens. Electrophysiological analysis confirmed this finding and suggested that the neuroprotection could result from a transient reduction in energy requirements owing to a transient reduction in nerve activity. These findings indicate that T–cell autoimmunity in the central nervous system, under certain circumstances, can exert a beneficial effect by protecting injured neurons from the spread of damage.

[1]  D. Hovda,et al.  Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: evidence of a hyper- and subsequent hypometabolic state , 1991, Brain Research.

[2]  I. Cohen,et al.  T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. , 1992, The Journal of clinical investigation.

[3]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[4]  M. Schwartz,et al.  Systemic humoral factors participating in the course of spinal cord injury , 1983, Paraplegia.

[5]  D. McAdoo,et al.  Hydroxyl Radicals Generated In Vivo Kill Neurons in the Rat Spinal Cord: Electrophysiological, Histological, and Neurochemical Results , 1994, Journal of neurochemistry.

[6]  A. Maleci,et al.  Immunocomplexes in rat and rabbit spinal cord after injury , 1987, Experimental Neurology.

[7]  H. Wallny,et al.  A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes , 1989, The Journal of experimental medicine.

[8]  S. Bonini,et al.  Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. , 1997, The Journal of allergy and clinical immunology.

[9]  N. Bazan,et al.  Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. , 1995, Journal of neurotrauma.

[10]  H. Hartung,et al.  IMMUNOLOGICALLY INDUCED ELECTROPHYSIOLOGICAL DYSFUNCTION: IMPLICATIONS FOR INFLAMMATORY DISEASES OF THE CNS AND PNS , 1997, Progress in Neurobiology.

[11]  Eric O Long,et al.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. , 1990, Journal of immunology.

[12]  R. Reynolds,et al.  The Distribution of Inflammatory Demyelinated Lesions in the Central Nervous System of Rats with Antibody-Augmented Demyelinating Experimental Allergic Encephalomyelitis , 1994, Experimental Neurology.

[13]  T. Mcintosh Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. , 1993, Journal of neurotrauma.

[14]  M. Sela,et al.  Basic encephalitogenic protein: A simplified purification on sulphoethyl‐sephadex , 1970, FEBS letters.

[15]  M. Schwartz,et al.  Transplantation of activated macrophages overcomes central nervous system regrowth failure , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  R. Martin Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies. , 1997, Journal of neural transmission. Supplementum.

[17]  M. Schwartz,et al.  Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats , 1998, Nature Medicine.

[18]  M. Schwartz,et al.  Cross talk between the immune system and the nervous system in response to injury: implications for regeneration , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  L. Steinman,et al.  The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.

[20]  M. Schwab,et al.  Rat CNS white matter, but not gray matter, is nonpermissive for neuronal cell adhesion and fiber outgrowth , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  I. Cohen Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. , 1991, Annual review of immunology.

[22]  H. Weiner,et al.  T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.

[23]  I. Cohen,et al.  Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. , 1988, Science.

[24]  I. Cohen,et al.  Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Hickey,et al.  T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.

[26]  V. Lev-Ram,et al.  Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin , 1983, Nature.

[27]  C. Whitacre,et al.  Concept of autoimmunity following spinal cord injury: Possible roles for T lymphocytes in the traumatized central nervous system , 1996, Journal of neuroscience research.

[28]  F. Barone,et al.  Brain Cooling During Transient Focal Ischemia Provides Complete Neuroprotection , 1997, Neuroscience & Biobehavioral Reviews.

[29]  E. Yoles,et al.  HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy. , 1996, Journal of neurotrauma.

[30]  I. Cohen,et al.  Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat. , 1995, Journal of immunology.

[31]  I. Cohen The cognitive paradigm and the immunological homunculus. , 1992, Immunology today.

[32]  I. Cohen,et al.  Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. , 1993, The Journal of clinical investigation.

[33]  D. Lynch,et al.  Secondary mechanisms in neuronal trauma. , 1994, Current opinion in neurology.

[34]  I. Cohen,et al.  The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.

[35]  B. Zweiman,et al.  Isolation of myelin basic protein-reactive T-cell lines from normal human blood. , 1983, Cellular immunology.

[36]  Irun R Cohen,et al.  Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma , 1998, Journal of Neuroimmunology.

[37]  P. Matzinger Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[38]  Michal Schwartz,et al.  Degeneration of Spared Axons Following Partial White Matter Lesion: Implications for Optic Nerve Neuropathies , 1998, Experimental Neurology.

[39]  S. Waxman,et al.  The pathophysiology of anoxic injury in central nervous system white matter. , 1990, Stroke.

[40]  E. Yoles,et al.  GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve. , 1992, Investigative ophthalmology & visual science.

[41]  J. Wayne Streilein,et al.  Unraveling Immune Privilege , 1995, Science.

[42]  A. Faden,et al.  Pharmacological strategies in CNS trauma. , 1992, Trends in pharmacological sciences.

[43]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.

[44]  M. Schwartz,et al.  Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. , 1990, Restorative neurology and neuroscience.

[45]  L. Santambrogio,et al.  Nerve growth factor production by lymphocytes. , 1994, Journal of immunology.

[46]  D. Hovda,et al.  Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study , 1991, Brain Research.

[47]  H. Wekerle,et al.  Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. , 1985, Journal of immunology.

[48]  T. Beardsley Cross reaction. Could AIDS really be an autoimmune disease? , 1991, Scientific American.

[49]  I. Cohen,et al.  T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells , 1983, European journal of immunology.

[50]  A. Faden Experimental neurobiology of central nervous system trauma. , 1993, Critical reviews in neurobiology.

[51]  P. Erb,et al.  Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Kappos,et al.  Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[53]  E. Yoles,et al.  NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. , 1997, Journal of neurotrauma.

[54]  J. Streilein,et al.  Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. , 1993, Current opinion in immunology.